{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:26:59Z","timestamp":1783348019410,"version":"3.54.6"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04903-5","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T05:15:31Z","timestamp":1778562931000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mapping the evolution of inflammatory bowel disease care in Brazil: a comparison of cross-sectional surveys from 2017 and 2023"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2266-2542","authenticated-orcid":false,"given":"Marta Brenner","family":"Machado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1858-3446","authenticated-orcid":false,"given":"Andreia","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7340-743X","authenticated-orcid":false,"given":"Silvana Paiva","family":"Orlandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8791-3520","authenticated-orcid":false,"given":"Mariana Otero","family":"Xavier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7755-5295","authenticated-orcid":false,"given":"Let\u00edcia Becari Cal","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Izabel Lamounier","family":"de Vasconcelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8901-2600","authenticated-orcid":false,"given":"Luciana Schuck","family":"Guedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"issue":"2","key":"4903_CR1","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nrgastro.2016.181","volume":"14","author":"S Singh","year":"2017","unstructured":"Singh S, Dulai PS, Zarrinpar A, Ramamoorthy S, Sandborn WJ. Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes. Nat Rev Gastroenterol Hepatol. 2017;14(2):110\u201321.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"4903_CR2","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1186\/s12889-023-17431-8","volume":"23","author":"JL Zhou","year":"2023","unstructured":"Zhou JL, Bao JC, Liao XY, Chen YJ, Wang LW, Fan YY, et al. Trends and projections of inflammatory bowel disease at the global, regional and national levels, 1990\u20132050: a bayesian age-period-cohort modeling study. BMC Public Health. 2023;23(1):2507.","journal-title":"BMC Public Health"},{"key":"4903_CR3","doi-asserted-by":"publisher","first-page":"100298","DOI":"10.1016\/j.lana.2022.100298","volume":"13","author":"AB Quaresma","year":"2022","unstructured":"Quaresma AB, Damiao AOMC, Coy CSR, Magro DO, Hino AAF, Valverde DA, et al. Temporal trends in the epidemiology of inflammatory bowel diseases in the public healthcare system in Brazil: A large population-based study. Lancet Reg Health - Americas. 2022;13:100298.","journal-title":"Lancet Reg Health - Americas"},{"key":"4903_CR4","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1002\/ibd.20545","volume":"14","author":"RD Johnston","year":"2008","unstructured":"Johnston RD, Logan RFA. What is the peak age for onset of IBD? Inflamm Bowel Dis. 2008;14:S4\u20135.","journal-title":"Inflamm Bowel Dis"},{"issue":"Supplement1","key":"4903_CR5","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1093\/jcag\/gwy048","volume":"2","author":"JL Jones","year":"2019","unstructured":"Jones JL, Nguyen GC, Benchimol EI, Bernstein CN, Bitton A, Kaplan GG, et al. The Impact of Inflammatory Bowel Disease in Canada 2018: Quality of Life. J Can Association Gastroenterol. 2019;2(Supplement1):S42\u20138.","journal-title":"J Can Association Gastroenterol"},{"issue":"Supplement1","key":"4903_CR6","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1093\/jcag\/gwy052","volume":"2","author":"EI Benchimol","year":"2019","unstructured":"Benchimol EI, Bernstein CN, Bitton A, Murthy SK, Nguyen GC, Lee K, et al. The Impact of Inflammatory Bowel Disease in Canada 2018: A Scientific Report from the Canadian Gastro-Intestinal Epidemiology Consortium to Crohn\u2019s and Colitis Canada. J Can Association Gastroenterol. 2019;2(Supplement1):S1\u20135.","journal-title":"J Can Association Gastroenterol"},{"issue":"1","key":"4903_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s12664-022-01303-x","volume":"42","author":"E Cross","year":"2023","unstructured":"Cross E, Saunders B, Farmer AD, Prior JA. Diagnostic delay in adult inflammatory bowel disease: A systematic review. Indian J Gastroenterol. 2023;42(1):40\u201352.","journal-title":"Indian J Gastroenterol"},{"issue":"6","key":"4903_CR8","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/apt.17370","volume":"57","author":"N Jayasooriya","year":"2023","unstructured":"Jayasooriya N, Baillie S, Blackwell J, Bottle A, Petersen I, Creese H, et al. Systematic review with meta-analysis: Time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease. Aliment Pharmacol Ther. 2023;57(6):635\u201352.","journal-title":"Aliment Pharmacol Ther"},{"key":"4903_CR9","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12913-015-0854-8","volume":"15","author":"C Davy","year":"2015","unstructured":"Davy C, Bleasel J, Liu H, Tchan M, Ponniah S, Brown A. Effectiveness of chronic care models: opportunities for improving healthcare practice and health outcomes: a systematic review. BMC Health Serv Res. 2015;15:194.","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"4903_CR10","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1006\/ebeh.2000.0105","volume":"1","author":"B Austin","year":"2000","unstructured":"Austin B, Wagner E, Hindmarsh M, Davis C. Elements of effective chronic care: a model for optimizing outcomes for the chronically ill. Epilepsy Behav. 2000;1(4):S15\u201320.","journal-title":"Epilepsy Behav"},{"key":"4903_CR11","doi-asserted-by":"publisher","first-page":"469","DOI":"10.4103\/jehp.jehp_1242_24","volume":"14","author":"ZS Shahrezai","year":"2025","unstructured":"Shahrezai ZS, Emami MH, Farzi S, Tarrahi MJ. The effect of chronic care model on self-efficacy and health-related quality of life of patients with ulcerative colitis: a randomized controlled trial. J Educ Health Promot. 2025;14:469.","journal-title":"J Educ Health Promot"},{"issue":"12","key":"4903_CR12","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1016\/j.amjmed.2025.08.015","volume":"138","author":"D Godfrey","year":"2025","unstructured":"Godfrey D, Koczanowski S, Selvarajah J, Gao W, Segal J, Pellino G. Exploring the evidence that supports the benefits of the multidisciplinary team in inflammatory bowel disease. Am J Med. 2025;138(12):1724\u2013e17331.","journal-title":"Am J Med"},{"key":"4903_CR13","doi-asserted-by":"crossref","unstructured":"Brenner Machado M, Steinwurz F, Zaltman C, Mendes Santos Quintiliano P, Mendes Moreira De Andrade Melo M, Paiva Orlandi S, et al. Mapping patient journey in inflammatory bowel disease in Brazil: a cross-sectional descriptive study based on an online survey. https:\/\/preprints.scielo.org\/index.php\/scielo\/preprint\/view\/11878\/version\/12518. Accessed 21 June 2025.","DOI":"10.1590\/SciELOPreprints.11878"},{"issue":"1","key":"4903_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.crohns.2007.06.005","volume":"1","author":"S Ghosh","year":"2007","unstructured":"Ghosh S, Mitchell R. Impact of inflammatory bowel disease on quality of life: Results of the European Federation of Crohn\u2019s and Ulcerative Colitis Associations (EFCCA) patient survey. J Crohn\u2019s Colitis. 2007;1(1):10\u201320.","journal-title":"J Crohn\u2019s Colitis"},{"issue":"10114","key":"4903_CR15","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2017","unstructured":"Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769\u201378.","journal-title":"Lancet"},{"issue":"spe3","key":"4903_CR16","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1590\/0103-11042018s312","volume":"42","author":"L Bahia","year":"2018","unstructured":"Bahia L, Scheffer M. O SUS e o setor privado assistencial: interpreta\u00e7\u00f5es e fatos. Sa\u00fade debate. 2018;42(spe3):158\u201371.","journal-title":"Sa\u00fade debate"},{"issue":"3","key":"4903_CR17","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s10880-021-09801-4","volume":"29","author":"M Feeney","year":"2022","unstructured":"Feeney M, Chur-Hansen A, Mikocka-Walus A. People Living with Inflammatory Bowel Disease Want Multidisciplinary Healthcare: A Qualitative Content Analysis. J Clin Psychol Med Settings. 2022;29(3):570\u20137.","journal-title":"J Clin Psychol Med Settings"},{"issue":"4","key":"4903_CR18","first-page":"otaf063","volume":"7","author":"D Napolitano","year":"2025","unstructured":"Napolitano D, Scaldaferri F, Leone S, Previtali E, Fiorino G, Caprioli F, et al. The dedicated inflammatory bowel disease nurse, if you know them, you love them: survey of the Italian IBD patients\u2019 association. Crohns Colitis 360. 2025;7(4):otaf063.","journal-title":"Crohns Colitis 360"},{"key":"4903_CR19","doi-asserted-by":"publisher","first-page":"175628482110066","DOI":"10.1177\/17562848211006669","volume":"14","author":"G Privitera","year":"2021","unstructured":"Privitera G, Pugliese D, Lopetuso LR, Scaldaferri F, Neri M, Guidi L, et al. Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches. Th Adv Gastroenterol. 2021;14:17562848211006669.","journal-title":"Th Adv Gastroenterol"},{"issue":"4","key":"4903_CR20","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.3390\/jcm14041357","volume":"14","author":"P Markopoulos","year":"2025","unstructured":"Markopoulos P, Gaki A, Kokkotis G, Chalakatevaki K, Kioulos N, Kitsou V, et al. Temporal Trends in the Use of Biological Agents in Patients with Inflammatory Bowel Disease: Real-World Data from a Tertiary Inflammatory Bowel Disease Greek Center During a 5-Year Period. JCM. 2025;14(4):1357.","journal-title":"JCM"},{"key":"4903_CR21","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Portaria no 49, de 22 de outubro de 2019. Torna p\u00fablica a decis\u00e3o de incorporar o infliximabe e o vedolizumabe para tratamento da retocolite ulcerativa moderada a grave no \u00e2mbito do Sistema \u00danico de Sa\u00fade (SUS). Di\u00e1rio Oficial da Uni\u00e3o. 2019. https:\/\/bvsms.saude.gov.br\/bvs\/saudelegis\/sctie\/2019\/prt0049_23_10_2019.html. Accessed 14 Apr 2025."},{"issue":"2","key":"4903_CR22","doi-asserted-by":"publisher","first-page":"e70114","DOI":"10.1002\/pds.70114","volume":"34","author":"CT De Castro","year":"2025","unstructured":"De Castro CT, Dos Santos Natividade M, Pereira M, Miranda SS, Arag\u00e3o E, De Souza Teles Santos CA, et al. Geographic and Temporal Patterns in Biologic Prescriptions for Inflammatory Bowel Diseases in the Public Healthcare System in Brazil: An Ecological Study. Pharmacoepidemiology Drug. 2025;34(2):e70114.","journal-title":"Pharmacoepidemiology Drug"},{"key":"4903_CR23","unstructured":"Guarini A. Satisfaction and expectations of patients with inflammatory bowel disease on biologic therapy: a multicenter study. aog. 2016. http:\/\/www.annalsgastro.gr\/files\/journals\/1\/earlyview\/2016\/ev-10-2016-07-AG2852-0100.pdf. Accessed 21 June 2025."},{"issue":"1","key":"4903_CR24","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12876-021-01781-x","volume":"21","author":"FGM Palacio","year":"2021","unstructured":"Palacio FGM, De Souza LMP, Moreira JPDL, Luiz RR, De Souza HSP, Zaltman C. Hospitalization and surgery rates in patients with inflammatory bowel disease in Brazil: a time-trend analysis. BMC Gastroenterol. 2021;21(1):192.","journal-title":"BMC Gastroenterol"},{"issue":"10","key":"4903_CR25","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1007\/s10620-020-06698-1","volume":"66","author":"L Dibley","year":"2021","unstructured":"Dibley L, Khoshaba B, Artom M, Van Loo V, Sweeney L, Syred J, et al. Patient Strategies for Managing the Vicious Cycle of Fatigue, Pain and Urgency in Inflammatory Bowel Disease: Impact, Planning and Support. Dig Dis Sci. 2021;66(10):3330\u201342.","journal-title":"Dig Dis Sci"},{"issue":"12","key":"4903_CR26","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1093\/ecco-jcc\/jjaa126","volume":"14","author":"PC Grunert","year":"2020","unstructured":"Grunert PC, Reuken PA, Stallhofer J, Teich N, Stallmach A. Inflammatory Bowel Disease in the COVID-19 Pandemic: the Patients\u2019 Perspective. J Crohn\u2019s Colitis. 2020;14(12):1702\u20138.","journal-title":"J Crohn\u2019s Colitis"},{"issue":"30","key":"4903_CR27","doi-asserted-by":"publisher","first-page":"993","DOI":"10.15585\/mmwr.mm6930e1","volume":"69","author":"MW Tenforde","year":"2020","unstructured":"Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March\u2013June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"4903_CR28","first-page":"otaf061","volume":"7","author":"D Napolitano","year":"2025","unstructured":"Napolitano D, Cilluffo S, Amatucci V, Bartoli D, Biagioli V, Martella P, et al. Self-care in patients with inflammatory bowel disease: a descriptive cross-sectional multicenter study. Crohns Colitis 360. 2025;7(4):otaf061.","journal-title":"Crohns Colitis 360"},{"issue":"11","key":"4903_CR29","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.3390\/jcm14113868","volume":"14","author":"D Napolitano","year":"2025","unstructured":"Napolitano D, et al. Self-care and resilience in patients with inflammatory bowel disease: clinical and psychosocial implications. J Clin Med. 2025;14(11):3868.","journal-title":"J Clin Med"},{"key":"4903_CR30","unstructured":"Instituto Brasileiro de Geografia e Estat\u00edstica (IBGE). PNAD Cont\u00ednua TIC 2017: Internet chega a tr\u00eas em cada quatro domic\u00edlios do pa\u00eds. IBGE News Agency. 2018. https:\/\/agenciadenoticias.ibge.gov.br\/agencia-sala-de-imprensa\/2013-agencia-de-noticias\/releases\/23445-pnad-continua-tic-2017-internet-chega-a-tres-em-cada-quatro-domicilios-do-pais. Accessed 29 March 2026."},{"key":"4903_CR31","unstructured":"Instituto Brasileiro de Geografia e Estat\u00edstica (IBGE). Internet foi acessada em 72,5 milh\u00f5es de domic\u00edlios do pa\u00eds em 2023. IBGE News Agency. 2024. https:\/\/agenciadenoticias.ibge.gov.br\/agencia-noticias\/2012-agencia-de-noticias\/noticias\/41024-internet-foi-acessada-em-72-5-milhoes-de-domicilios-do-pais-em-2023. Accessed 29 March 2026."}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04903-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04903-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04903-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:07:51Z","timestamp":1783346871000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04903-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4903"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04903-5","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"9 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki and was approved by the Research Ethics Committee of the Faculty of Medicine at the Federal University of Pelotas (Research Protocol No. 7.422.232). All participants provided an online informed consent form before participating in the study. All data were collected anonymously, and no personally identifiable information was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Machado MB has received fees for serving as a speaker and\/or an advisory board for Takeda, Janssen, AbbVie, Ferring, and Pfizer. Vieira A has received fees for serving as a speaker and\/or an advisory board for Takeda, Janssen, AbbVie, Ferring, and Pfizer. De Vasconcelos MI has received fees for serving as a speaker and\/or an advisory board for Nestl\u00e9. Guedes LS has received fees for serving as a medical advisor for Adium. The other authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"413"}}